SC has admitted plea of generic drug manufacturer Cipla Ltd challenging Delhi HC order holding it guilty of infringing Swiss pharma company Hoffmann-La Roche's patent over lung cancer drug Erlotinib.
Tags : SC CIPLA HOFFMANN-LA ROCHE
Share :